Bill Anderson, who assumed leadership of Bayer in June, is eyeing cuts to the company’s mid- and upper-management. In addition to the cost-savings, Anderson expects the cuts to streamline decision-making. The moves are part of Anderson’s first step in bolder initiative to revamp Bayer’s operational dynamics in the face of investor pressures. It is relatively…
Bayer announces €3 million disaster relief fund for Ukraine
Bayer (ETR:BAYN) will offer additional support to international and local humanitarian aid organizations serving Ukraine and neighboring countries. Immediately after Russia’s invasion of Ukraine, Bayer had pledged to spend €300,000 in aid. Now, it has committed €3 million in additional humanitarian aid. Roche, Sanofi and Novo Nordisk have announced similar initiatives for Ukraine. Bayer has…
Gene therapy specialist Viralgen opens new facility in Spain’s Basque Country
San Sebastián, Spain–headquartered Viralgen, has opened a new factory in Basque Country in northern Spain. The company focuses on manufacturing adeno-associated virus (AAV) vectors, which are used in gene therapy and some vaccines. Since 2018, Viralgen has offered AAV manufacturing for customers working in preclinical through Phase 2 development programs. The company has licensed its…